Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
News and Views
Nature Biotechnology 26, 397–398 (1 April 2008) | doi:10.1038/nbt0408-397
Toward a renewable source of pancreatic |[beta]|-cells
&
Abstract
Patients with type 1 diabetes or severe forms of type 2 diabetes may greatly benefit from transplantation of pancreatic β-cells. Given the shortage of donor islets, human embryonic stem (hES) cells represent an attractive source of β-cells, but to be clinically useful stem cell–derived β-cells must be capable of secreting fully processed insulin in response to physiological concentrations of glucose.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
